Aberrant JAK/STAT Signaling Suppresses TFF1 and TFF2 through Epigenetic Silencing of GATA6 in Gastric Cancer

By Wu Cheng-Shyong   Wei Kuo-Liang   Chou Jian-Liang   Lu Chung-Kuang   Hsieh Ching-Chuan   Lin Jora M. J.   Deng Yi-Fang   Hsu Wan-Ting   Wang Hui-Min David   Leung Chung-Hang   Ma Dik-Lung   Li Chin   Chan Michael W. Y.  

International Journal of Molecular Sciences, Vol. 17, Iss. 9, 2016-09 ,pp. : 1467-1467

MDPI

Access to resources Recommend Favorite

Integrating Immunologic Signaling Networks: The JAK/STAT Pathway in Colitis and Colitis-Associated Cancer

By Zundler Sebastian   Neurath Markus F.  

Vaccines, Vol. 4, Iss. 1, 2016-02 ,pp. : 5-5

MDPI

Access to resources Recommend Favorite

Negative Regulators of JAK/STAT Signaling in Rheumatoid Arthritis and Osteoarthritis

By Malemud Charles J.  

International Journal of Molecular Sciences, Vol. 18, Iss. 3, 2017-02 ,pp. : 484-484

MDPI

Access to resources Recommend Favorite

HiJAK’d Signaling; the STAT3 Paradox in Senescence and Cancer Progression

By Junk Damian J.   Bryson Benjamin L.   Jackson Mark W.  

Cancers, Vol. 6, Iss. 2, 2014-03 ,pp. : 741-755

MDPI

Access to resources Recommend Favorite

Viral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-Antagonists

By Fleming Stephen B.  

Vaccines, Vol. 4, Iss. 3, 2016-06 ,pp. : 23-23

MDPI

Access to resources Recommend Favorite